Overview

Study to Evaluate the Drug-drug Interaction Effect of Omeprazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

Status:
Completed
Trial end date:
2020-01-26
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the PK profile of AMG 510 alone and in combination with omeprazole in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Amgen
Treatments:
Omeprazole